CN115040525A - Slimming fat solution and preparation method thereof - Google Patents

Slimming fat solution and preparation method thereof Download PDF

Info

Publication number
CN115040525A
CN115040525A CN202210726164.7A CN202210726164A CN115040525A CN 115040525 A CN115040525 A CN 115040525A CN 202210726164 A CN202210726164 A CN 202210726164A CN 115040525 A CN115040525 A CN 115040525A
Authority
CN
China
Prior art keywords
parts
slimming
chinese medicine
traditional chinese
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210726164.7A
Other languages
Chinese (zh)
Inventor
方维
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taizhou Meiyitian Medical Technology Co ltd
Original Assignee
Taizhou Meiyitian Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taizhou Meiyitian Medical Technology Co ltd filed Critical Taizhou Meiyitian Medical Technology Co ltd
Priority to CN202210726164.7A priority Critical patent/CN115040525A/en
Publication of CN115040525A publication Critical patent/CN115040525A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8984—Dendrobium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Abstract

The invention provides a slimming fat-dissolving liquid and a preparation method thereof, wherein the slimming fat-dissolving liquid comprises the following raw materials in parts by weight: 300 parts of normal saline 200-one, 0.5-0.8 part of lidocaine, 3-5 parts of vitamin B complex, 1-3 parts of aminophylline, 0.5-1 part of triamcinolone acetonide or methylprednisolone and 0.6-1.2 parts of traditional Chinese medicine extract. The invention has the beneficial effects that: the slimming fat-dissolving liquid provided by the invention directly acts on subcutaneous fat, has an obvious effect, is small in side effect and quick to recover, and does not influence the normal life of a user. The weight-reducing fat-dissolving liquid has the advantages of light pain of patients in the injection process, convenient operation and incomparable advantages for the treatment of local obesity.

Description

Slimming fat solution and preparation method thereof
Technical Field
The invention belongs to the technical field of medical cosmetology, and particularly relates to a slimming fat solution and a preparation method thereof.
Background
Obesity is a common group of metabolic disorders. Factors causing obesity include various factors such as irregular diet, abnormal work and rest, genetic, endocrine disorders, environmental factors, etc. The obesity not only affects the external appearance of people, especially women have higher requirements on the stature, but also causes some diseases, and medical researches prove that severe obesity can cause various damages to human bodies and can induce or aggravate diseases such as hypertension, hyperlipoidemia, coronary heart disease, diabetes, fatty liver, obstructive sleep dyspnea, arthritis, gout, osteoporosis, tumors and the like.
Currently, treatments for obesity include drug therapy and surgical therapy, in addition to diet control and physical activity enhancement. At present, orlistat, lorcaserin, L-carnitine and other weight-reducing medicines can be selected, but because of adverse drug reactions and drug resistance, how to safely and effectively apply the medicines in clinic still needs to be discussed, and meanwhile, the actual curative effect of many weight-reducing health-care products is mostly unsatisfactory. The fat dissolving needle produced by transportation means that a medicine is directly injected into a subcutaneous fat layer of a human body to dissolve fat, and the first fat dissolving injection kybella is approved by the Food and Drug Administration (FDA) in 2015 globally, so that the fat dissolving needle is suitable for adults with moderate and severe double-chin. At present, no relevant report of fat dissolving needle exists in China.
Disclosure of Invention
The invention aims to provide a safe and effective slimming fat solution and a preparation method thereof.
In order to achieve the purpose, the invention adopts the following technical scheme:
a fat solution for reducing weight comprises the following raw materials in parts by weight: 300 parts of normal saline 200-one, 0.5-0.8 part of lidocaine, 3-5 parts of vitamin B complex, 1-3 parts of aminophylline, 0.5-1 part of triamcinolone acetonide or methylprednisolone and 0.6-1.2 parts of traditional Chinese medicine extract.
The slimming fat solution as a preferred embodiment comprises the following raw materials in parts by weight: 280 parts of normal saline 220-sodium bicarbonate, 0.6-0.7 part of lidocaine, 3-4 parts of vitamin B complex, 1-2 parts of aminophylline, 0.6-0.8 part of triamcinolone acetonide or methylprednisolone and 0.8-1.0 part of traditional Chinese medicine extract.
The slimming fat solution as a preferred embodiment comprises the following raw materials in parts by weight: 260 parts of normal saline, 0.6 part of lidocaine, 4 parts of vitamin B complex, 2 parts of aminophylline, 0.7 part of triamcinolone acetonide or methylprednisolone and 0.9 part of traditional Chinese medicine extract.
Lidocaine is a very good local anaesthetic, generally acting after one to three minutes of administration, with the effect remaining for one to three hours.
The vitamin B complex is a compound preparation, and each tablet contains 13 mg of main components of vitamin B, 21.5 mg of vitamin B, 60.2 mg of vitamin B, 10 mg of nicotinamide and 1 mg of calcium pantothenate. The auxiliary materials are as follows: starch, dextrin, calcium hydrogen phosphate and magnesium stearate. It can be used for preventing and treating malnutrition, anorexia, beriberi, and pellagra caused by vitamin B deficiency.
Aminophylline is a compound salt of theophylline and ethylenediamine, and the pharmacological action of aminophylline mainly comes from theophylline, and ethylenediamine enhances the water solubility of the aminophylline. It has the strongest relaxing effect on bronchial smooth muscle, can dilate bronchus, increase vital capacity, and has lasting effect, especially on spastic bronchus.
Triamcinolone acetonide is a synthetic corticosteroid used to treat various skin disorders or to alleviate discomfort associated with oral ulcers.
As a preferred embodiment, the weight-reducing fat solution comprises the following raw materials in parts by weight: 5-15 parts of dendrobium officinale, 4-6 parts of cistanche, 3-8 parts of pseudo-ginseng, 8-12 parts of kudzuvine root, 4-6 parts of plantain seed and 3-5 parts of astragalus.
Dendrobium officinale is sweet in taste and slightly cold in nature, has the function of promoting the production of body fluid and is mainly characterized by promoting glandular secretion and organ movement.
Cistanche genus, Orobanchaceae family, warm in nature and sweet in flavor. Cistanche parasitism is a parasitic plant at the root of desert tree haloxylon ammodendron, and nutrients and water are absorbed from haloxylon ammodendron hosts, which is quite reputable as desert ginseng. Cistanchis herba has effects of invigorating kidney yang, replenishing essence and blood, and moistening intestinal tract, and can be used for treating essence and blood deficiency, lumbago, asthenia, tinnitus, blurred vision, and infertility due to cold womb. Besides, the cistanche deserticola has the functions of resisting aging, improving the immunity of the organism and promoting the synthesis of deoxyribonucleic acid.
Notoginseng radix is Araliaceae plant of Umbelliferae, has sweet, slightly bitter and warm nature, and has effects of removing blood stasis, stopping bleeding, subsiding swelling and relieving pain. In addition, Notoginseng radix has antiinflammatory and liver protecting effects, and Notoginseng radix saponin in Notoginseng radix has anti-tumor effect.
Radix Puerariae is dried root of Pueraria lobata Ohwi of Leguminosae, has sweet taste and cool nature, and has effects of relieving muscles and fever, promoting eruption, promoting fluid production to quench thirst, invigorating yang and relieving diarrhea; it is commonly used to treat exterior syndrome fever, stiffness and pain of neck and back, measles without adequate eruption, fever thirst, yin deficiency with thirst, heat diarrhea and dysentery, spleen deficiency with diarrhea, etc.
Semen plantaginis is dry mature seed of Plantago asiatica or Plantago depressa of Plantaginaceae, and has effects of promoting diuresis, clearing heat, improving eyesight, and eliminating phlegm. It is commonly used to treat urinary obstruction, stranguria with turbid urine, leukorrhagia, hematuria, summer-heat-dampness dysentery, cough with excessive phlegm, damp arthralgia, conjunctival congestion and nebula.
Radix astragali is root of Astragalus membranaceus bge or Astragalus membranaceus bge of Leguminosae, and is one of the commonly used Chinese medicinal materials. Astragalus root has the effects of invigorating qi, consolidating superficial resistance, expelling pus, healing sore and promoting granulation, and is often used for treating qi deficiency, hypodynamia, sinking of middle-jiao energy, internal heat and diabetes. In addition, radix astragali can also enhance immunity, and has antitumor and osteoporosis resisting effects.
In a second aspect of the present application, there is provided a method for preparing a slimming solution, comprising the steps of:
(1) preparing a traditional Chinese medicine extract;
(2) sterilizing the traditional Chinese medicine extract, adding normal saline, lidocaine, vitamin B complex, aminophylline, triamcinolone acetonide or methylprednisolone into the sterilized traditional Chinese medicine extract, mixing and stirring uniformly, and sterilizing to obtain the slimming fat solution.
As a preferred embodiment, in the step (1), the specific operation of preparing the traditional Chinese medicine extract is as follows:
extracting herba Dendrobii, Cistanchis herba, Notoginseng radix, radix Puerariae, semen plantaginis and radix astragali with ethanol under reflux, concentrating the extractive solution, freeze drying, and sterilizing to obtain the Chinese medicinal extract.
The above method for preparing a slimming solution, as a preferred embodiment, the freeze-drying is: freeze drying at-10 deg.C to-6 deg.C for 18-28 h.
In the above method for preparing a slimming solution, as a preferred embodiment, in step (2), the sterilization is ultrasonic sterilization.
As a preferable embodiment, the ultrasonic frequency of the ultrasonic sterilization is 15-30KHz, and the ultrasonic sterilization time is 10-50 min.
The invention has the beneficial effects that: the slimming fat-dissolving liquid provided by the invention directly acts on subcutaneous fat, has an obvious effect, is small in side effect and quick to recover, and does not influence the normal life of a user. The weight-reducing fat-dissolving liquid has the advantages of light pain of patients in the injection process, convenient operation and incomparable advantages for the treatment of local obesity.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the technical solutions of the present invention will be described in detail below. It is to be understood that the described embodiments are merely a few embodiments of the invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the examples given herein without any inventive step, are within the scope of the present invention.
Example 1
The weight reducing fat solution in the embodiment 1 comprises the following raw materials in parts by weight: 200 parts of normal saline, 0.5 part of lidocaine, 3 parts of vitamin B complex, 1 part of aminophylline, 0.5 part of triamcinolone acetonide and 0.6 part of traditional Chinese medicine extract;
the traditional Chinese medicine extract consists of the following raw materials in parts by weight: 5 parts of dendrobium officinale, 6 parts of cistanche, 8 parts of pseudo-ginseng, 8 parts of kudzu root, 4 parts of plantain seed and 3 parts of astragalus membranaceus.
The method for preparing the slimming solution of example 1 comprises the following steps:
(1) preparing a traditional Chinese medicine extract; extracting herba Dendrobii, Cistanchis herba, Notoginseng radix, radix Puerariae, semen plantaginis and radix astragali with ethanol under reflux, concentrating the extractive solution, and freeze drying at-10 deg.C for 18 hr to obtain the Chinese medicinal extract;
(2) sterilizing the Chinese medicinal extract (ultrasonic sterilizing with 15KHz ultrasonic frequency for 15min), adding normal saline, lidocaine, vitamin B complex, aminophylline, and triamcinolone acetonide into the sterilized Chinese medicinal extract, mixing, stirring, and sterilizing with 15KHz ultrasonic frequency for 15min to obtain the slimming fat dissolving liquid.
Example 2
The weight reducing fat solution in the embodiment 2 comprises the following raw materials in parts by weight: 220 parts of normal saline, 0.6 part of lidocaine, 3 parts of vitamin B complex, 2 parts of aminophylline, 0.6 part of methylprednisolone and 0.8 part of traditional Chinese medicine extract;
the traditional Chinese medicine extract comprises the following raw materials in parts by weight: 10 parts of dendrobium officinale, 4 parts of cistanche, 5 parts of pseudo-ginseng, 8 parts of kudzu root, 5 parts of plantain seed and 3 parts of astragalus membranaceus.
The preparation method of the slimming solution of embodiment 2 comprises the following steps:
(1) preparing a traditional Chinese medicine extract; extracting herba Dendrobii, Cistanchis herba, Notoginseng radix, radix Puerariae, semen plantaginis and radix astragali with ethanol under reflux, concentrating the extractive solution, and freeze drying at-8 deg.C for 20 hr to obtain the Chinese medicinal extract;
(2) sterilizing the Chinese medicinal extract (ultrasonic sterilizing with 20KHz ultrasonic frequency for 12min), adding normal saline, lidocaine, vitamin B complex, aminophylline, and methylprednisolone into the sterilized Chinese medicinal extract, mixing, stirring, and sterilizing with 20KHz ultrasonic frequency for 15min to obtain the slimming fat-dissolving liquid.
Example 3
The weight reducing fat solution in embodiment 3 comprises the following raw materials in parts by weight: 260 parts of normal saline, 0.6 part of lidocaine, 4 parts of vitamin B complex, 2 parts of aminophylline, 0.7 part of triamcinolone acetonide and 0.9 part of traditional Chinese medicine extract;
the traditional Chinese medicine extract comprises the following raw materials in parts by weight: 10 parts of dendrobium officinale, 5 parts of cistanche, 5 parts of pseudo-ginseng, 10 parts of kudzu root, 5 parts of plantain seed and 4 parts of astragalus membranaceus.
The method for preparing the slimming solution of example 3 comprises the following steps:
(1) preparing a traditional Chinese medicine extract; extracting herba Dendrobii, Cistanchis herba, Notoginseng radix, radix Puerariae, semen plantaginis and radix astragali with ethanol under reflux, concentrating the extractive solution, and freeze drying at-6 deg.C for 20 hr to obtain the Chinese medicinal extract;
(2) sterilizing the Chinese medicinal extract (ultrasonic sterilizing with ultrasonic frequency of 25KHz for 12min), adding normal saline, lidocaine, vitamin B complex, aminophylline, and triamcinolone acetonide into the sterilized Chinese medicinal extract, mixing, stirring, and sterilizing with ultrasonic frequency of 25KHz for 12min to obtain the slimming fat dissolving liquid.
Example 4
The weight reducing fat solution in embodiment 4 comprises the following raw materials in parts by weight: 280 parts of normal saline, 0.7 part of lidocaine, 4 parts of vitamin B complex, 2 parts of aminophylline, 0.8 part of triamcinolone acetonide and 1.0 part of traditional Chinese medicine extract;
the traditional Chinese medicine extract comprises the following raw materials in parts by weight: 12 parts of dendrobium officinale, 5 parts of cistanche, 6 parts of pseudo-ginseng, 10 parts of kudzu root, 5 parts of plantain seed and 5 parts of astragalus membranaceus.
The method for preparing the slimming solution of example 4 comprises the following steps:
(1) preparing a traditional Chinese medicine extract; extracting herba Dendrobii, Cistanchis herba, Notoginseng radix, radix Puerariae, semen plantaginis and radix astragali with ethanol under reflux, concentrating the extractive solution, and freeze drying at-10 deg.C for 18 hr to obtain the Chinese medicinal extract;
(2) sterilizing the Chinese medicinal extract (ultrasonic sterilizing with 28KHz for 12min), adding normal saline, lidocaine, vitamin B complex, aminophylline, and triamcinolone acetonide into the sterilized Chinese medicinal extract, mixing, stirring, and sterilizing with 28KHz ultrasonic for 15min to obtain the weight reducing fat dissolving liquid.
Example 5
The fat-reducing solution of embodiment 5 comprises the following raw materials in parts by weight: 300 parts of normal saline, 0.8 part of lidocaine, 3 parts of vitamin B complex, 3 parts of aminophylline, 1 part of triamcinolone acetonide and 1.2 parts of traditional Chinese medicine extract;
the traditional Chinese medicine extract comprises the following raw materials in parts by weight: 5 parts of dendrobium officinale, 4 parts of cistanche, 8 parts of pseudo-ginseng, 8 parts of kudzu root, 6 parts of plantain seed and 3 parts of astragalus membranaceus.
The method for preparing the slimming solution of example 5 comprises the following steps:
(1) preparing a traditional Chinese medicine extract; extracting herba Dendrobii, Cistanchis herba, Notoginseng radix, radix Puerariae, semen plantaginis and radix astragali with ethanol under reflux, concentrating the extractive solution, and freeze drying at-10 deg.C for 28 hr to obtain the Chinese medicinal extract;
(2) sterilizing the Chinese medicinal extract (ultrasonic sterilizing with 30KHz ultrasonic frequency for 15min), adding normal saline, lidocaine, vitamin B complex, aminophylline, and triamcinolone acetonide into the sterilized Chinese medicinal extract, mixing, stirring, and sterilizing with 30KHz ultrasonic frequency for 15min to obtain the slimming fat dissolving liquid.
The application method of the slimming fat solution comprises the following steps: the range of fat accumulation is marked locally, and a needle point convenient for inserting the syringe is marked in the range, and the injection amount is about 20ml each time.
The above description is only a preferred embodiment of the present application and is not intended to limit the present application, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, improvement and the like made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims (9)

1. The weight-reducing fat solution is characterized by comprising the following raw materials in parts by weight: 300 parts of normal saline 200-one, 0.5-0.8 part of lidocaine, 3-5 parts of vitamin B complex, 1-3 parts of aminophylline, 0.5-1 part of triamcinolone acetonide or methylprednisolone and 0.6-1.2 parts of traditional Chinese medicine extract.
2. The slimming fat solution according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 280 parts of normal saline 220-sodium bicarbonate, 0.6-0.7 part of lidocaine, 3-4 parts of vitamin B complex, 1-2 parts of aminophylline, 0.6-0.8 part of triamcinolone acetonide or methylprednisolone and 0.8-1.0 part of traditional Chinese medicine extract.
3. The slimming fat solution according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 260 parts of normal saline, 0.6 part of lidocaine, 4 parts of vitamin B complex, 2 parts of aminophylline, 0.7 part of triamcinolone acetonide or methylprednisolone and 0.9 part of traditional Chinese medicine extract.
4. The slimming lipid solution according to claim 1, wherein the traditional Chinese medicine extract is prepared from the following raw materials in parts by weight: 5-15 parts of dendrobium officinale, 4-6 parts of cistanche, 3-8 parts of pseudo-ginseng, 8-12 parts of kudzuvine root, 4-6 parts of plantain seed and 3-5 parts of astragalus.
5. A process for the preparation of a slimming solution according to any one of claims 1 to 4, characterized by comprising the following steps:
(1) preparing a traditional Chinese medicine extract;
(2) sterilizing the traditional Chinese medicine extract, adding normal saline, lidocaine, vitamin B complex, aminophylline, triamcinolone acetonide or methylprednisolone into the sterilized traditional Chinese medicine extract, mixing and stirring uniformly, and sterilizing to obtain the slimming fat solution.
6. The method for preparing a slimming solution according to claim 5, wherein the step (1) of preparing the herbal extract comprises the following specific steps:
extracting herba Dendrobii, Cistanchis herba, Notoginseng radix, radix Puerariae, semen plantaginis and radix astragali with ethanol under reflux, concentrating the extractive solution, freeze drying, and sterilizing to obtain the Chinese medicinal extract.
7. The method for preparing a slimming solution of claim 6, wherein the freeze-drying is: freeze drying at-10 deg.C to-6 deg.C for 18-28 h.
8. The method for preparing a slimming solution of claim 6, wherein in the step (2), the sterilization is ultrasonic sterilization.
9. The method for preparing a slimming solution according to claim 8, wherein the ultrasonic frequency of the ultrasonic sterilization is 15 to 30KHz, and the ultrasonic sterilization time is 10 to 50 min.
CN202210726164.7A 2022-06-23 2022-06-23 Slimming fat solution and preparation method thereof Pending CN115040525A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210726164.7A CN115040525A (en) 2022-06-23 2022-06-23 Slimming fat solution and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210726164.7A CN115040525A (en) 2022-06-23 2022-06-23 Slimming fat solution and preparation method thereof

Publications (1)

Publication Number Publication Date
CN115040525A true CN115040525A (en) 2022-09-13

Family

ID=83164052

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210726164.7A Pending CN115040525A (en) 2022-06-23 2022-06-23 Slimming fat solution and preparation method thereof

Country Status (1)

Country Link
CN (1) CN115040525A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102308988A (en) * 2011-07-08 2012-01-11 云南普洱思松科贸有限责任公司 Dendrobium health product having function of human body immunization enhancement
KR20200144249A (en) * 2019-06-18 2020-12-29 주식회사 하큐셀 Cosmetic composition for decomposing fat
CN114246238A (en) * 2022-01-17 2022-03-29 闫洁 Cistanche salsa and gardenia health tea

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102308988A (en) * 2011-07-08 2012-01-11 云南普洱思松科贸有限责任公司 Dendrobium health product having function of human body immunization enhancement
KR20200144249A (en) * 2019-06-18 2020-12-29 주식회사 하큐셀 Cosmetic composition for decomposing fat
CN114246238A (en) * 2022-01-17 2022-03-29 闫洁 Cistanche salsa and gardenia health tea

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周秋丽等主编: "现代中药基础研究与临床", vol. 1, 天津科技翻译出版公司, pages: 222 - 223 *

Similar Documents

Publication Publication Date Title
CN104146261B (en) Traditional Chinese medicine health care product of a kind of Woman climacteric and preparation method thereof
CN102895349A (en) Traditional Chinese medicine tea for treating hypertension, hyperlipidemia and hyperglycemia
CN103536778B (en) Traditional Chinese medicine preparation for treating cephalagra
CN105394282A (en) Radix puerariae health tea capable of reducing blood pressure, blood sugar and blood lipid
CN105079676A (en) Medicine for treating fatty liver and preparing method of medicine
CN102526581B (en) Chinese medicinal composition for treating hypertension diseases
CN115040525A (en) Slimming fat solution and preparation method thereof
CN104623583A (en) Asthenia cold abdominalgia treating drug and preparation method of asthenia cold abdominalgia treating drug oral liquid
CN103705639B (en) One treats hydrocephalic Chinese medicine preparation
CN105213758A (en) A kind of Chinese medicine composition for the treatment of chronic pneumonia and preparation method thereof
CN104435136B (en) A kind of pharmaceutical composition promoting union of fracture and preparation method thereof
CN104474015A (en) Medicine for lowering blood pressure and blood fat and preparation method of medicine
CN1562253A (en) Health foods in use for improving symptom in climacteric period of female and fabricating method
CN104922488A (en) Traditional Chinese medicine composition for preventing and curing Parkinson's disease or Parkinson's disease motor complications and preparing method and application thereof
CN103341054B (en) Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof
CN109420039A (en) A kind of Chinese medicine treated diabetes and merge hypoglycemia
CN101810751B (en) Chinese medicinal preparation for treating pediatric mesenteric lymph node inflammation
CN105878732A (en) Traditional Chinese medicine for curing diabetes and preparation method thereof
CN104740193A (en) Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition
CN105709071A (en) Medicine for treating postnatal constipation and preparation method of medicine
CN104083610A (en) Traditional Chinese medicine preparation for treating climacteric metancholia
CN103933359A (en) Pharmaceutical composition for dispelling keloid and preparation method of pharmaceutical composition
CN109288969A (en) A kind of Chinese medicine composition and its preparation for treating artery sclerosis
CN103690644A (en) Traditional Chinese medicine preparation for promoting fracture rehabilitation
CN109453301A (en) Health liquor and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination